(Q24244110)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

1 reference

title

Probiotics for maintenance of remission in Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

V E Rolfe

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

P J Fortun

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

C J Hawkey

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

18 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

CD004826

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Saccharomyces boulardii in maintenance treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Probiotics and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Anti-tuberculous therapy for maintaining remission of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Probiotics as modulators of the gut flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

A pilot trial of Saccharomyces boulardii in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Variable response to probiotics in two models of experimental colitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Mucosal flora in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Structure of the intestinal flora responsible for development of the gut immune system in a rodent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

Use of Lactobacillus-GG in paediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

1 reference

7 January 2021

Probiotic therapy fails to improve gut permeability in a hapten model of colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

The effect of dietary yeast on the activity of stable chronic Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004826.PUB2

7 January 2021

10.1002/14651858.CD004826.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3260921

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054217%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

3260921

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

3260921